Cargando…
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma
Protein tyrosine kinase 7 (PTK7), also known as colon carcinoma kinase 4 (CCK-4), is a member of the catalytically defective receptor protein tyrosine kinase family and is upregulated in various cancers, where it is known to act as either an oncoprotein or a tumor suppressor. To understand the contr...
Autores principales: | Shin, Won-Sik, Gim, Jungsoo, Won, Sungho, Lee, Seung-Taek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986804/ https://www.ncbi.nlm.nih.gov/pubmed/29867084 http://dx.doi.org/10.1038/s41598-018-26957-6 |
Ejemplares similares
-
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022) -
Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
por: Kim, Jae Hoon, et al.
Publicado: (2022) -
PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells
por: Shin, Won-Sik, et al.
Publicado: (2022) -
Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells
por: Shin, Won-Sik, et al.
Publicado: (2016) -
Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF
por: Shin, Won-Sik, et al.
Publicado: (2019)